SCHEMBL21369905

SCHEMBL21369905

c1ccc(-c2nc(-c3cc(-c4cc5ccccc5c5ccccc45)cc(-n4c5ccccc5c5ccccc54)c3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 3/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369890 0.95 CYP11B1 (0.34) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369805 0.93 CYP11B1 (0.40) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369807 0.93 CYP11B1 (0.42) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369878 0.91 CYP1A1 (0.44) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21370366 0.91 CYP1A1 (0.41) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369806 0.91 CYP11B1 (0.39) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21370170 0.90 CYP11B1 (0.40) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21370172 0.90 CYP11B1 (0.40) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369963 0.90 CYP11B1 (0.40) CYP11B1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21369684 0.90 L3MBTL1 (0.41) CYP11B1KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CYP11B1 37/4885KDM4E 2473/4885MEN1 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.